Court of Justice of European Union Rules on Updating of Documentation of Medicinal Products Subject to Parallel Import Licence
- 13/10/2020
- Articles
Attached is a note discussing the judgment of the Court of Justice of the European Union (CJEU) in kohlpharma II. The judgment deals with updates to the documentation of medicinal products subject to a parallel import licence in situations where the marketing authorisation of the reference product in the Member State of importation has expired. It appears that the CJEU attaches a greater weight to the free movement principles than to the protection of public health.